Cargando…
A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands
BACKGROUND: Chlamydia prevalence in the Netherlands remains high despite targeted efforts. Effective Partner Notification (PN) and Partner Treatment (PT) can interrupt transmission and prevent re-infections. Patient Initiated Partner Treatment (PIPT) may strengthen chlamydia control. This study expl...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975518/ https://www.ncbi.nlm.nih.gov/pubmed/29843643 http://dx.doi.org/10.1186/s12879-018-3139-0 |
_version_ | 1783327001637027840 |
---|---|
author | Nanhoe, Anita C. Visser, Maartje Omlo, Jurriaan J. Watzeels, Anita J. C. M. van den Broek, Ingrid V. Götz, Hannelore M. |
author_facet | Nanhoe, Anita C. Visser, Maartje Omlo, Jurriaan J. Watzeels, Anita J. C. M. van den Broek, Ingrid V. Götz, Hannelore M. |
author_sort | Nanhoe, Anita C. |
collection | PubMed |
description | BACKGROUND: Chlamydia prevalence in the Netherlands remains high despite targeted efforts. Effective Partner Notification (PN) and Partner Treatment (PT) can interrupt transmission and prevent re-infections. Patient Initiated Partner Treatment (PIPT) may strengthen chlamydia control. This study explores the current practice of PN and PT, and benefits of, and barriers and facilitators for PIPT among professionals in sexual health care in the Netherlands. METHODS: A qualitative study was performed among GPs, GP-assistants (GPAs), physicians and nurses working at Sexual Health Clinics (SHC) and key-informants on ethnical diversity using topic lists in focus groups (N = 40) and semi-structured questionnaires in individual interviews (N = 9). Topics included current practices regarding PN and PT, attitude regarding PIPT, and perceived barriers and facilitators for PIPT. Interviews were taped, transcribed verbatim, and coded using ATLAS.ti. A quantitative online questionnaire on the same topics was sent to all physicians and nurses employed at Dutch SHC (complete response rate 26% (84/321)). RESULTS: The qualitative study showed that all professionals support the need for more attention to PN, and that they saw advantages in PIPT. Mentioned barriers included unwilling PN-behaviour, Dutch legislation, several medical considerations and inadequate skills of GPs. Also, concerns about limited knowledge of cultural sensitivity around PN and PT were raised. Mentioned facilitators of PIPT were reliable home based test-kits, phone-contact between professionals and notified partners, more consultation time for GPs or GPAs and additional training. The online questionnaire showed that SHC employees agreed that partners should be treated as soon as possible, but also that they were reluctant towards PIPT without counselling and testing. CONCLUSIONS: Professionals saw advantages in PIPT, but they also identified barriers hampering the potential introduction of PIPT. Improving PN and counselling skills with specific focus on cultural sensitivity is needed. PIPT could be considered for specific partners. PIPT in combination with home based testing and using e-healthcare should be further explored and developed. |
format | Online Article Text |
id | pubmed-5975518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59755182018-05-31 A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands Nanhoe, Anita C. Visser, Maartje Omlo, Jurriaan J. Watzeels, Anita J. C. M. van den Broek, Ingrid V. Götz, Hannelore M. BMC Infect Dis Research Article BACKGROUND: Chlamydia prevalence in the Netherlands remains high despite targeted efforts. Effective Partner Notification (PN) and Partner Treatment (PT) can interrupt transmission and prevent re-infections. Patient Initiated Partner Treatment (PIPT) may strengthen chlamydia control. This study explores the current practice of PN and PT, and benefits of, and barriers and facilitators for PIPT among professionals in sexual health care in the Netherlands. METHODS: A qualitative study was performed among GPs, GP-assistants (GPAs), physicians and nurses working at Sexual Health Clinics (SHC) and key-informants on ethnical diversity using topic lists in focus groups (N = 40) and semi-structured questionnaires in individual interviews (N = 9). Topics included current practices regarding PN and PT, attitude regarding PIPT, and perceived barriers and facilitators for PIPT. Interviews were taped, transcribed verbatim, and coded using ATLAS.ti. A quantitative online questionnaire on the same topics was sent to all physicians and nurses employed at Dutch SHC (complete response rate 26% (84/321)). RESULTS: The qualitative study showed that all professionals support the need for more attention to PN, and that they saw advantages in PIPT. Mentioned barriers included unwilling PN-behaviour, Dutch legislation, several medical considerations and inadequate skills of GPs. Also, concerns about limited knowledge of cultural sensitivity around PN and PT were raised. Mentioned facilitators of PIPT were reliable home based test-kits, phone-contact between professionals and notified partners, more consultation time for GPs or GPAs and additional training. The online questionnaire showed that SHC employees agreed that partners should be treated as soon as possible, but also that they were reluctant towards PIPT without counselling and testing. CONCLUSIONS: Professionals saw advantages in PIPT, but they also identified barriers hampering the potential introduction of PIPT. Improving PN and counselling skills with specific focus on cultural sensitivity is needed. PIPT could be considered for specific partners. PIPT in combination with home based testing and using e-healthcare should be further explored and developed. BioMed Central 2018-05-29 /pmc/articles/PMC5975518/ /pubmed/29843643 http://dx.doi.org/10.1186/s12879-018-3139-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Nanhoe, Anita C. Visser, Maartje Omlo, Jurriaan J. Watzeels, Anita J. C. M. van den Broek, Ingrid V. Götz, Hannelore M. A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands |
title | A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands |
title_full | A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands |
title_fullStr | A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands |
title_full_unstemmed | A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands |
title_short | A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands |
title_sort | pill for the partner via the chlamydia patient? results from a mixed method study among sexual health care providers in the netherlands |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975518/ https://www.ncbi.nlm.nih.gov/pubmed/29843643 http://dx.doi.org/10.1186/s12879-018-3139-0 |
work_keys_str_mv | AT nanhoeanitac apillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands AT vissermaartje apillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands AT omlojurriaanj apillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands AT watzeelsanitajcm apillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands AT vandenbroekingridv apillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands AT gotzhannelorem apillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands AT nanhoeanitac pillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands AT vissermaartje pillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands AT omlojurriaanj pillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands AT watzeelsanitajcm pillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands AT vandenbroekingridv pillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands AT gotzhannelorem pillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands |